Strs Ohio Zentalis Pharmaceuticals, Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 21, 2022	SELL	$41.58 - $80.89 $457,380 - $889,790	-11,000 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$66.92 - $84.79 $381,444 - $483,303	5,700 Added 107.55%	11,000 $924,000
Q3 2021 Oct 22, 2021	BUY	$46.83 - $73.5 $70,245 - $110,250	1,500 Added 39.47%	5,300 $353,000
Q2 2021 Jul 26, 2021	BUY	$37.41 - $62.25 $14,963 - $24,900	400 Added 11.76%	3,800 $202,000
Q4 2020 Jan 25, 2021	BUY	$31.71 - $57.97 $22,197 - $40,579	700 Added 25.93%	3,400 $176,000
Q2 2020 Jul 23, 2020	BUY	$23.2 - $54.8 $62,640 - $147,960	2,700 New	2,700 $129,000

142

67.9M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $170M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.